Home › Sjogren's Syndrome › Pennsylvania
Sjogren's Syndrome clinical trials in Pennsylvania
4 studies for Sjogren's Syndrome are looking for participants at sites in Pennsylvania.
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Altoona Center for Clin Res, Duncansville
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT07737743Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Altoona Center for Clinical Research, P.C., Duncansville
- Rheumatic Disease Associates, Ltd., Willow Grove
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865The Myelin Disorders Biorepository Project
- The Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
All ages · All sexes · Updated Oct 23, 2025 · NCT03047369From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.